Edwards Lifesciences Corp
EW- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001099800
In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 10 sales; 1,344 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Edwards Lifesciences Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 10 filings
- 6 insiders, $4.54M in total
- Insiders trading
- 6
- Net value
- −$4.54M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Edwards Lifesciences Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Markowitz Wayne | CVP, JAPAC | 19,371 | Sep 14, 2026 | 6 |
| Dahl Andrew M. | SVP, Corporate Controller | 14,615 | Sep 14, 2026 | 6 |
| Chopra Daveen | CVP, TMTT, Surgical & IHFM | 43,926 | Sep 11, 2026 | 7 |
| Lippis Daniel J. | CVP, TAVR | 40,034 | Sep 11, 2026 | 16 |
| Bruls Annette | CVP, EMEACLA | 17,984 | Aug 28, 2026 | 3 |
| Zovighian Bernard J | CEO | 8,916Indirect | Jul 27, 2026 | 7 |
| Mistras Theodora | CVP, Chief Financial Officer | 99,920 | Jul 10, 2026 | 1 |
| Bobo Donald E Jr | CVP,Strategy/Corp Development | 98,611Indirect | May 27, 2026 | 11 |
| Ullem Scott B. | CVP, Chief Financial Officer | 46,740 | May 11, 2026 | 8 |
| Laviolette Paul A | Director | 17,552 | May 8, 2026 | 1 |
| Loranger Steven R | Director | 8,997 | May 8, 2026 | 1 |
| Stone Heisz Leslie | Director | 34,199 | May 8, 2026 | 2 |
| Valeriani Nicholas J | Director | 84,423 | May 8, 2026 | 1 |
| Gallahue Kieran | Director | 4,315 | May 8, 2026 | 1 |
| Feinberg David T | Director | 9,087 | May 8, 2026 | 1 |
| Sequeira Ramona | Director | 6,779 | May 8, 2026 | 1 |
| Davis Leslie C. | Director | 9,834 | May 8, 2026 | 1 |
| Wood Larry L | Global President TAVR & Surg | 206,900 | Aug 18, 2025 | 0 |
| Szyman Catherine M. | CVP, Critical Care | 81,287 | Sep 3, 2024 | 0 |
| Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 184,686 | Jul 8, 2024 | 0 |
| Sellers Robert W.A. | SVP, Corporate Controller | 17,081 | May 13, 2024 | 0 |
| Mussallem Michael A | Director | 4,486 | May 2, 2024 | 0 |
| Marsh Martha H. | Director | 31,880 | May 15, 2023 | 0 |
| Wang Huimin | CVP, Japan & Intercontinental | 99,381 | Jul 8, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 (view filing) | Sep 10 | Same day | Bobo Donald E JrCVP,Strategy/Corp Development | SSale | −11.1K | $122.26 | −$1.35M | −16.4%56.4K after | 2 lots |
| Sep 10, 2021 (view filing) | Sep 10 | Same day | Wood Larry LCVP, TAVR | SSale | −7.83K | $122.59 | −$959.9K | −2.1%372.1K after | |
| Sep 8, 2021 (view filing) | Sep 8 | Same day | Wang HuiminCVP, Japan & Intercontinental | SSale | −6.35K | $121.25 | −$769.9K | −6.1%98.0K after | |
| Sep 8, 2021 (view filing) | Sep 8 | Same day | Szyman Catherine M.CVP, Critical Care | SSale | −9.74K | $121.28 | −$1.18M | −26.2%27.4K after | |
| Aug 10, 2021 (view filing) | Aug 10 | Same day | Wood Larry LCVP, TAVR | SSale | −7.83K | $114.14 | −$893.7K | −2.1%372.1K after | |
| Aug 9, 2021 (view filing) | Aug 9 | Same day | Wang HuiminCVP, Japan & Intercontinental | SSale | −6.35K | $115.54 | −$733.7K | −6.1%98.0K after | |
| Aug 6, 2021 (view filing) | Aug 6 | Same day | Bobo Donald E JrCVP,Strategy/Corp Development | SSale | −11.1K | $114.37 | −$1.26M | −16.4%56.4K after | |
| Aug 3, 2021 (view filing) | Aug 3 | Same day | Mussallem Michael AChairman & CEO | SSale | −32.5K | $114.14 | −$3.72M | −14.8%188.0K after | 2 lots |
| Aug 2, 2021 (view filing) | Aug 2 | Same day | Szyman Catherine M.CVP, Critical Care | SSale | −15.0K | $113.53 | −$1.70M | −35.1%27.8K after | |
| Jul 12, 2021 (view filing) | Jul 12 | Same day | Wood Larry LCVP, TAVR | SSale | −7.83K | $107.48 | −$841.6K | −2.1%372.1K after | |
| Jul 9, 2021 (view filing) | Jul 9 | Same day | Bobo Donald E JrCVP,Strategy/Corp Development | SSale | −11.1K | $108.15 | −$1.20M | −16.4%56.4K after | |
| Jul 8, 2021 (view filing) | Jul 8 | Same day | Wang HuiminCVP, Japan & Intercontinental | SSale | −6.35K | $106.72 | −$677.7K | −6.1%98.0K after | |
| Jul 1, 2021 (view filing) | Jul 1 | Same day | Mussallem Michael AChairman & CEO | SSale | −32.5K | $104.61 | −$3.40M | −14.8%188.0K after | 2 lots |